Top

Published in:

01-02-2019 | Invited Review

Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment

Authors: Souhil Lebdai, Armand Chevrot, Steeve Doizi, Benjamin Pradere, Nicolas Barry Delongchamps, Amine Benchikh, Jean Nicolas Cornu, Emmanuel Della Negra, Marc Fourmarier, Vincent Misraï, Pierre Etienne Theveniaud, Aurélien Descazeaud, Grégoire Robert, For the CTMH-AFU group

Published in: World Journal of Urology | Issue 2/2019

Abstract

Purpose

Ejaculatory dysfunction is the most common side effect related to surgical treatment of benign prostatic obstruction (BPO). Nowadays, modified surgical techniques and non-ablative techniques have emerged with the aim of preserving antegrade ejaculation. Our objective was to conduce a systematic review of the literature regarding efficacy on ejaculatory preservation of modified endoscopic surgical techniques, and mini-invasive non-ablatives techniques for BPO management.

Methods

A systematic review of the literature was carried out on the PubMed database using the following MESH terms: “Prostatic Hyperplasia/surgery” and “Ejaculation”, in combination with the following keywords: “ejaculation preservation”, “photoselective vaporization of the prostate”, “photoselective vapo-enucleation of the prostate”, “holmium laser enucleation of the prostate”, “thulium laser”, “prostatic artery embolization”, “urolift”, “rezum”, and “aquablation”.

Results

The ejaculation preservation rate of modified-TURP ranged from 66 to 91%. The ejaculation preservation rate of modified-prostate photo-vaporization ranged from 87 to 96%. The only high level of evidence studies available compared prostatic urethral lift (PUL) and aquablation versus regular TURP in prospective randomized-controlled trials. The ejaculation preservation rate of either PUL or aquablation compared to regular TURP was 100 and 90 versus 34%, respectively.

Conclusions

Non-ablative therapies and modified endoscopic surgical techniques seemed to be reasonable options for patients eager to preserve their ejaculatory functions.

Marra G, Sturch P, Oderda M et al (2016) Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men’s ejaculatory function: time for a bespoke approach? Int J Urol Off J Jpn Urol Assoc 23:22–35. https://doi.org/10.1111/iju.12866 CrossRef

Descazeaud A, Robert G, Delongchamps NB et al (2012) Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association. Prog En Urol J Assoc Fr Urol Société Fr Urol 22:977–988. https://doi.org/10.1016/j.purol.2012.10.001 CrossRef

Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67:1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038 CrossRefPubMed

Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int 83:227–237CrossRefPubMed

Ronzoni G, De Vecchis M (1998) Preservation of anterograde ejaculation after transurethral resection of both the prostate and bladder neck. Br J Urol 81:830–833CrossRefPubMed

Alloussi SH, Lang C, Eichel R, Alloussi S (2014) Ejaculation-preserving transurethral resection of prostate and bladder neck: short- and long-term results of a new innovative resection technique. J Endourol Endourol Soc 28:84–89. https://doi.org/10.1089/end.2013.0093 CrossRef

Talab SS, Santiago-Lastra YA, Bachmann A et al (2013) V403 the impact of ejaculation-preserving photo-selective vaporization of the prostate (EP-PVP) on lower urinary tract symptoms and ejaculatory function: results of a multicenter study. J Urol 189:e164. https://doi.org/10.1016/j.juro.2013.02.1792 CrossRef

Kim M, Song SH, Ku JH et al (2015) Pilot study of the clinical efficacy of ejaculatory hood sparing technique for ejaculation preservation in holmium laser enucleation of the prostate. Int J Impot Res 27:20–24. https://doi.org/10.1038/ijir.2014.22 CrossRefPubMed

Roehrborn CG, Barkin J, Gange SN et al (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 24:8802–8813PubMed

10.

Gratzke C, Barber N, Speakman MJ et al (2017) Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int 119:767–775. https://doi.org/10.1111/bju.13714 CrossRefPubMed

11.

Pisco J, Bilhim T, Pinheiro LC et al (2016) Prostate embolization as an alternative to open surgery in patients with large prostate and moderate to severe lower urinary tract symptoms. J Vasc Interv Radiol JVIR 27:700–708. https://doi.org/10.1016/j.jvir.2016.01.138 CrossRefPubMed

12.

Mynderse LA, Hanson D, Robb RA et al (2015) Rezūm system water vapor treatment for lower urinary tract symptoms/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. Urology 86:122–127. https://doi.org/10.1016/j.urology.2015.03.021 CrossRefPubMed

13.

Durieux N, Vandenput S, Pasleau F (2013) OCEBM levels of evidence system. Rev Médicale Liège 68:644–649

14.

Brookes ST, Donovan JL, Peters TJ et al (2002) Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ 324:1059–1061CrossRefPubMedPubMedCentral

15.

Chen Q, Zhang L, Fan Q-L et al (2010) Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU Int 106:1339–1343. https://doi.org/10.1111/j.1464-410X.2010.09401.x CrossRefPubMed

16.

Møller-Nielsen C, Lundhus E, Møller-Madsen B et al (1985) Sexual life following “minimal” and “total” transurethral prostatic resection. Urol Int 40:3–4CrossRefPubMed

17.

Ahyai SA, Lehrich K, Kuntz RM (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 52:1456–1463. https://doi.org/10.1016/j.eururo.2007.04.053 CrossRefPubMed

18.

Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016. https://doi.org/10.1097/01.ju.0000136218.11998.9e CrossRefPubMed

19.

Placer J, Salvador C, Planas J et al (2015) Effects of holmium laser enucleation of the prostate on sexual function. J Endourol 29:332–339. https://doi.org/10.1089/end.2014.0502 CrossRefPubMed

20.

Thomas JA, Tubaro A, Barber N et al (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol 69:94–102. https://doi.org/10.1016/j.eururo.2015.07.054 CrossRefPubMed

21.

Yee CLS, Pal RP, Batchelder A, Khan MA (2012) Risk of erectile dysfunction and retrograde ejaculation associated with thulium laser vaporesection of the prostate for bladder outflow obstruction: a retrospective study. Urol Int 88:165–169. https://doi.org/10.1159/000333046 CrossRefPubMed

22.

Xia S-J, Zhuo J, Sun X-W et al (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53:382–389. https://doi.org/10.1016/j.eururo.2007.05.019 CrossRefPubMed

23.

Yang Q, Peters TJ, Donovan JL et al (2001) Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: a systematic review and meta-analysis of randomized controlled trials. J Urol 165:1526–1532CrossRefPubMed

24.

Lourenco T, Shaw M, Fraser C et al (2010) The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials. World J Urol 28:23–32. https://doi.org/10.1007/s00345-009-0496-8 CrossRefPubMed

25.

Reich O, Gratzke C, Stief CG (2006) Techniques and long-term results of surgical procedures for BPH. Eur Urol 49:970–978. https://doi.org/10.1016/j.eururo.2005.12.072 CrossRefPubMed

26.

Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118–140. https://doi.org/10.1016/j.eururo.2013.03.004 CrossRefPubMed

27.

Rynja S, Bosch R, Kok E et al (2010) IIEF-15: unsuitable for assessing erectile function of young men? J Sex Med 7:2825–2830. https://doi.org/10.1111/j.1743-6109.2010.01847.x CrossRefPubMed

28.

Rosen RC, Catania JA, Althof SE et al (2007) Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology 69:805–809. https://doi.org/10.1016/j.urology.2007.02.036 CrossRefPubMed

29.

Rosen R, Altwein J, Boyle P et al (2003) Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44:637–649CrossRefPubMed

30.

Feldman HA, Goldstein I, Hatzichristou DG et al (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54–61CrossRefPubMed

31.

Kim JK, Cho MC, Son H et al (2017) Patient perception of ejaculatory volume reduction after holmium laser enucleation of the prostate (HoLEP). Urology 99:142–147. https://doi.org/10.1016/j.urology.2016.09.037 CrossRefPubMed

32.

Elshal AM, El-Assmy A, Mekkawy R et al (2017) Prospective controlled assessment of men’s sexual function changes following holmium laser enucleation of the prostate for treatment of benign prostate hyperplasia. Int Urol Nephrol 49:1741–1749. https://doi.org/10.1007/s11255-017-1649-0 CrossRefPubMed

33.

Hedlund H, Ek A (1985) Ejaculation and sexual function after endoscopic bladder neck incision. Br J Urol 57:164–167CrossRefPubMed

34.

Yang SS-D, Tsai Y-C, Chen J-J et al (2008) Modified transurethral incision of the bladder neck treating primary bladder neck obstruction in young men: a method to improve voiding function and to preserve antegrade ejaculation. Urol Int 80:26–30. https://doi.org/10.1159/000111725 CrossRefPubMed

35.

Gil-Vernet JM, Alvarez-Vijande R, Gil-Vernet A, Gil-Vernet JM (1994) Ejaculation in men: a dynamic endorectal ultrasonographical study. Br J Urol 73:442–448CrossRefPubMed

36.

Sturch P, Woo HH, McNicholas T, Muir G (2015) Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking? BJU Int 115:186–187. https://doi.org/10.1111/bju.12868 CrossRefPubMed

37.

Ben Rhouma S, Ben Chehida MA, Ahmed S et al (2016) MP42-18 can we preserve ejaculation after transurethral resection of the prostate? Comparative study between the conventional technique and a new technique about 70 cases. J Urol 195:e577. https://doi.org/10.1016/j.juro.2016.02.206 CrossRef

38.

Leonardi R (2009) Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis 12:277–280. https://doi.org/10.1038/pcan.2009.5 CrossRefPubMed

39.

Miyauchi T, Yusu H, Kanzaki M (2016) V3-06 ejaculation-sparing photoselective vaporization of the prostate: evaluation of the ejaculatory function and the lower urinary tract symptoms. J Urol 195:e468. https://doi.org/10.1016/j.juro.2016.02.1526 CrossRef

40.

Roehrborn CG, Rukstalis DB, Barkin J et al (2015) Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 22:7772–7782PubMed

41.

Carnevale FC, Iscaife A, Yoshinaga EM et al (2016) Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Interv Radiol 39:44–52. https://doi.org/10.1007/s00270-015-1202-4 CrossRef

42.

Gao Y, Huang Y, Zhang R et al (2014) Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology 270:920–928. https://doi.org/10.1148/radiol.13122803 CrossRefPubMed

43.

Amouyal G, Thiounn N, Pellerin O et al (2016) Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study. Cardiovasc Interv Radiol 39:367–375. https://doi.org/10.1007/s00270-015-1267-0 CrossRef

44.

Kuang M, Vu A, Athreya S (2017) A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia. Cardiovasc Interv Radiol 40:655–663. https://doi.org/10.1007/s00270-016-1539-3 CrossRef

45.

Roehrborn CG, Gange SN, Gittelman MC et al (2017) Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol 197:1507–1516. https://doi.org/10.1016/j.juro.2016.12.045 CrossRefPubMed

46.

McVary KT, Roehrborn CG (2017) Three-year outcomes of the prospective, randomized controlled Rezūm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. https://doi.org/10.1016/j.urology.2017.10.023

47.

Dixon C, Cedano ER, Pacik D et al (2015) Efficacy and safety of Rezūm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 86:1042–1047. https://doi.org/10.1016/j.urology.2015.05.046 CrossRefPubMed

48.

Gilling P, Anderson P, Tan A (2017) Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol 197:1565–1572. https://doi.org/10.1016/j.juro.2017.01.056 CrossRefPubMed

49.

Gilling P, Reuther R, Kahokehr A, Fraundorfer M (2016) Aquablation—image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int 117:923–929. https://doi.org/10.1111/bju.13358 CrossRefPubMed

50.

Gilling P, Barber N, Bidair M et al (2018) WATER—a double-blind randomized controlled trial of Aquablation vs. transurethral resection of the prostate in benign prostatic hyperplasia. J Urol. https://doi.org/10.1016/j.juro.2017.12.065

Title: Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment
Authors: Souhil Lebdai
Armand Chevrot
Steeve Doizi
Benjamin Pradere
Nicolas Barry Delongchamps
Amine Benchikh
Jean Nicolas Cornu
Emmanuel Della Negra
Marc Fourmarier
Vincent Misraï
Pierre Etienne Theveniaud
Aurélien Descazeaud
Grégoire Robert
For the CTMH-AFU group
Publication date: 01-02-2019
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 2/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2368-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?

Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy

Low-risk prostate cancer selected for active surveillance with negative MRI at entry: can repeat biopsies at 1 year be avoided? A pilot study

Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre

MRI-targeted biopsies: What’s next?

Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer